NeoGenomics, headquartered in Fort Myers, Florida, was the subject of a report regarding a strategy selling stock after CEO departure news on September 4, 2025.
2 reports, 2 independent
Updated Sep 14
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
NeoGenomics, headquartered in Fort Myers, Florida, was the subject of a report regarding a strategy selling stock after CEO departure news on September 4, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Mike Nassif was appointed CEO of Neogen to stabilize the executive team.Sub-event
NeoGenomics (HQ in Fort Myers, FL) was the subject of a report regarding a strategy selling stock after CEO departure news on September 4, 2025.1 source
Keep exploring
The entities involved
-
NeoGenomics
cancer genetics diagnostic testing company based in Fort Myers, Florida, USA
-
Villa Florida
city of the Department of Misiones, Paraguay
Nothing else this week.
Coverage
Newest first; wire copies grouped- tickerreport.com
- Insider MonkeyBrown Advisory Small-Cap Growth Strategy Sold Neogenomics (NEO) Following the News of CEO Departure Brown Advisory, an investment management company, released its "Brown Advisory Small-Cap Growth Str